Latest | F'cast | |
---|---|---|
Div Yield | 2.8% | |
Div Cover | 1.5 | |
Op Mrgn | 28.0% | |
ROCE | 40.1% |
Latest | F'cast | |
---|---|---|
P/E | 24.9 | |
PEG | 8.0 | |
Pr/Revenue | 5.9 | |
Pr/Book | 26.8 |
Latest | F'cast | |
---|---|---|
Revenue | 7.1% | |
PBT | 6.9% | |
EPS | 3.1% | |
DPS | 8.7% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 23,362.00 | 9,138.00 | 1,296.00¢ | 18.6 | 9.3 | +2% | 580.00¢ | 2.4% |
31-Dec-20 | 25,424.00 | 8,133.00 | 1,240.00¢ | 18.5 | n/a | -4% | 656.00¢ | 2.9% |
31-Dec-21 | 25,979.00 | 6,701.00 | 1,034.00¢ | 21.8 | n/a | -17% | 722.00¢ | 3.2% |
31-Dec-22 | 26,323.00 | 7,346.00 | 1,218.00¢ | 21.6 | 1.2 | +18% | 795.00¢ | 3.0% |
31-Dec-23 | 28,190.00 | 7,855.00 | 1,256.00¢ | 22.9 | 7.6 | +3% | 864.00¢ | 3.0% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 33,012.47 | 14,820.76 | 1,944.03¢ | 15.8 | 0.3 | +55% | 923.29¢ | 0.0% |
31-Dec-25 | 33,931.86 | 15,402.00 | 2,043.61¢ | 15.0 | 2.9 | +5% | 997.93¢ | 0.0% |
31-Dec-26 | 34,677.01 | 15,600.07 | 2,138.75¢ | 14.3 | 3.1 | +5% | 1,062.43¢ | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
SEP cashes in as US giant Amgen buys cancer drug... | 26-Jan-2011 | The Scotsman |
Amgen Buys a Cancer Drug Maker | 25-Jan-2011 | New York Times |
Tech Ticker | 16-Dec-2010 | BayArea.com |
Currency | US Dollars |
Share Price | $ 306.50 |
Change Today | $ -2.91 |
% Change | -0.94 % |
52 Week High | $324.56 |
52 Week Low | $214.27 |
Volume | 2,139,729 |
Shares Issued | 535.40m |
Market Cap | $164,100m |
RiskGrade | 100 |
Strong Buy | 6 |
Buy | 8 |
Neutral | 13 |
Sell | 1 |
Strong Sell | 1 |
Total | 29 |
Time | Volume / Share Price |
15:59 | 200 @ $306.44 |
15:59 | 200 @ $306.44 |
15:59 | 100 @ $306.49 |
15:59 | 109 @ $306.44 |
15:59 | 139 @ $306.44 |
You are here: research